SARS-CoV-2 Spike receptor binding domain, RBD (319-335)

Product Name: SARS-CoV-2 Spike receptor binding domain, RBD (319-335)

Sequence One Letter Code: RVQPTESIVRFPNITNL

Sequence Three Letter Code: H-Arg-Val-Gln-Pro-Thr-Glu-Ser-Ile-Val-Arg-Phe-Pro-Asn-Ile-Thr-Asn-Leu-OH

Molecular Weight: 1984.4

Purity: ≥ 95%

Storage Conditions: - 20 °C

Source / Species: SARS-CoV-2

Conjugation: Unconjugated

Code Nacres: NA.26

Application: SARS-CoV-2 Spike RBD (319–335) is a synthetic peptide corresponding to residues 319–335 of the SARS-CoV-2 spike protein receptor-binding domain. This region contributes to RBD structural integrity and host receptor interaction, making it relevant to studies of viral infectivity and immune recognition. The spike RBD is a primary target for neutralizing antibodies and receptor-binding research. SARS-CoV-2 Spike RBD (319–335) is widely used in virology, immunology, antibody development, epitope characterization, spike protein structure studies, and investigations of antigen–antibody interactions related to coronavirus entry mechanisms.